Miłosz Andrzej Zajączkowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miłosz Andrzej Zajączkowski has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Adam Kosiński
Division of Clinical Anatomy, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland
7 shared publications - Agata Kaczyńska
Division of Clinical Anatomy, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland
6 shared publications - Grzegorz Piwko
Division of Clinical Anatomy, Medical University of Gdańsk, Gdańsk, Poland
3 shared publications - Marta Gleinert-Rożek
Division of Clinical Anatomy, Medical University of Gdańsk, Gdańsk, Poland
3 shared publications - Rafał Kamiński
Department of Clinical Anatomy, Medical University of Gdansk, Poland
3 shared publications - Damian Jezyk
Division of Anatomy and Anthropology, Gdańsk University of Physical Education and Sport, Gdańsk, Poland
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1506
Mesenchymal Stromal Cells for Heart Diseases: Current Perspective and Future Directions
Cardiovascular diseases remain the leading cause of mortality worldwide and continue to impose a substantial clinical burden despite major advances in pharmacological and interventional therapies. Because the adult myocardium has limited regenerative capacity, irreversible cardiomyocyte loss frequently leads to adverse remodeling and progressive heart failure (HF). Mesenchymal stromal cells (MSCs) are among the most extensively studied cell therapies for cardiac repair because of their immunomodulatory, pro-angiogenic, anti-inflammatory, and anti-fibrotic effects, mediated predominantly through paracrine signaling. This review summarizes the current evidence for MSC-based therapy in ischemic heart disease (IHD), coronary and microvascular disorders, myocardial infarction, HF, myocarditis, pulmonary arterial hypertension, and valvular heart disease (VHD). We discuss MSC sources, preclinical and clinical evidence, manufacturing and dosing, delivery routes, biomaterial-assisted transplantation, preconditioning, genetic modification, and imaging for cell tracking and treatment monitoring. Although MSC therapy has shown a favorable safety profile and regenerative potential, clinical efficacy remains variable because of limited cell survival, poor myocardial retention, and heterogeneous treatment protocols. Further optimization of manufacturing, delivery, and patient selection, together with well-designed randomized trials, is required to establish standardized protocols and support clinical translation.
- 15 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1506
Open AccessMesenchymal Stromal Cells for Heart Diseases: Current Perspective and Future Directions
Cardiovascular diseases remain the leading cause of mortality worldwide and continue to impose a substantial clinical burden despite major advances in pharmacological and interventional therapies. Because the adult myocardium has limited regenerative capacity, irreversible cardiomyocyte loss frequently leads to adverse remodeling and progressive heart failure (HF). Mesenchymal stromal cells (MSCs) are among the most extensively studied cell therapies for cardiac repair because of their immunomodulatory, pro-angiogenic, anti-inflammatory, and anti-fibrotic effects, mediated predominantly through paracrine signaling. This review summarizes the current evidence for MSC-based therapy in ischemic heart disease (IHD), coronary and microvascular disorders, myocardial infarction, HF, myocarditis, pulmonary arterial hypertension, and valvular heart disease (VHD). We discuss MSC sources, preclinical and clinical evidence, manufacturing and dosing, delivery routes, biomaterial-assisted transplantation, preconditioning, genetic modification, and imaging for cell tracking and treatment monitoring. Although MSC therapy has shown a favorable safety profile and regenerative potential, clinical efficacy remains variable because of limited cell survival, poor myocardial retention, and heterogeneous treatment protocols. Further optimization of manufacturing, delivery, and patient selection, together with well-designed randomized trials, is required to establish standardized protocols and support clinical translation.
- Open Access
- 6 October 2026
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 48 (1) , 246
Morphological spectrum of the septal papillary muscle complex and chordal support in the human tricuspid valve: a quantitative anatomical study
- 6 October 2026
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 48 (1) , 246
Open AccessMorphological spectrum of the septal papillary muscle complex and chordal support in the human tricuspid valve: a quantitative anatomical study
- Open Access
- 19 December 2025
- Published by Gdanski Uniwersytet Medyczny in European Journal of Translational and Clinical Medicine
- Vol. 8 (2) , 25-34
The length and topographical location of septal papillary muscles in adult human hearts
The length and topographical location of septal papillary muscles in adult human hearts. Background: This study aimed to evaluate the relative length and anatomical position of septal papillary muscles, including the papillary muscle of...
- 19 December 2025
- Published by Gdanski Uniwersytet Medyczny in European Journal of Translational and Clinical Medicine
- Vol. 8 (2) , 25-34
Open AccessThe length and topographical location of septal papillary muscles in adult human hearts
The length and topographical location of septal papillary muscles in adult human hearts. Background: This study aimed to evaluate the relative length and anatomical position of septal papillary muscles, including the papillary muscle of...
- Open Access
- 5 November 2021
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 31 (1) , 33-40
Clinical anatomy of the spatial structure of the right ventricular outflow trac
The right ventricular outflow tract (RVOT) is located above the supraventricular crest and reaches the level of the pulmonary valve. Detailed knowledge of the RVOT spatial structure and its morphology is extremely important for cardiac invasive therapeutic procedures. To examine the spatial structure of the RVOT using virtual models of the right ventricle (RV) interior obtained post mortem. The study was carried out using 40 adult hearts from both sexes fixed in formalin. Donors had a negative history of cardiovascular diseases. Silicone models of the interior of the RV were made and then subjected to a digital modelling procedure using the photogrammetry technique. For each 3D model of the RV, the RVOT was extracted and measurements were performed. Statistical analysis demonstrated that the dimensions of the transverse (p < 0.001) and sagittal (p = 0.002) axis at the level of the upper and lower border of the RVOT differed significantly. There was also a significant difference between the right and left height of the RVOT (p = 0.009). A clear correlation was found between the volume of the RVOT and the volume of the entire RV (r = 0.718, p < 0.001). The obtained 3D models of the RVOT can help standardize the data related to RVOT architecture. Furthermore, they can extend knowledge about the RVOT in the field of cardiology and improve the procedures in cardiac surgery.
- 5 November 2021
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 31 (1) , 33-40
Open AccessClinical anatomy of the spatial structure of the right ventricular outflow trac
The right ventricular outflow tract (RVOT) is located above the supraventricular crest and reaches the level of the pulmonary valve. Detailed knowledge of the RVOT spatial structure and its morphology is extremely important for cardiac invasive therapeutic procedures. To examine the spatial structure of the RVOT using virtual models of the right ventricle (RV) interior obtained post mortem. The study was carried out using 40 adult hearts from both sexes fixed in formalin. Donors had a negative history of cardiovascular diseases. Silicone models of the interior of the RV were made and then subjected to a digital modelling procedure using the photogrammetry technique. For each 3D model of the RV, the RVOT was extracted and measurements were performed. Statistical analysis demonstrated that the dimensions of the transverse (p < 0.001) and sagittal (p = 0.002) axis at the level of the upper and lower border of the RVOT differed significantly. There was also a significant difference between the right and left height of the RVOT (p = 0.009). A clear correlation was found between the volume of the RVOT and the volume of the entire RV (r = 0.718, p < 0.001). The obtained 3D models of the RVOT can help standardize the data related to RVOT architecture. Furthermore, they can extend knowledge about the RVOT in the field of cardiology and improve the procedures in cardiac surgery.
- Open Access
- 9 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 359
Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in zebrafish, rats, and mice. The involvement of nitric oxide (NO) in the above effects was investigated. Concentration–dependent lethality, morphological defects, and decrease in heart rate (HR) were observed in zebrafish larvae. PS affected HR, blood pressure, respiratory rate, peak exhaled CO2, and blood oxygen saturation in rats. We observed hypotension, increase of HR, perfusion of paw vessels, and enhanced respiratory disturbances with increases doses of PS. We found no effects of PS on human hERG channels or signs of heart damage in mice. The hypotension in rats and bradycardia in zebrafish were partially attenuated by the inhibitor of endothelial NO synthase. The disturbances in cardiovascular and respiratory parameters were reduced or delayed when PS was administered together with UFH. The cardiorespiratory toxicity of PS seems to be charge–dependent and involves enhanced release of NO. PS administered at appropriate doses and ratios with UFH should not cause permanent damage of heart tissue, although careful monitoring of cardiorespiratory parameters is necessary.
- 9 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 359
Open AccessCardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in zebrafish, rats, and mice. The involvement of nitric oxide (NO) in the above effects was investigated. Concentration–dependent lethality, morphological defects, and decrease in heart rate (HR) were observed in zebrafish larvae. PS affected HR, blood pressure, respiratory rate, peak exhaled CO2, and blood oxygen saturation in rats. We observed hypotension, increase of HR, perfusion of paw vessels, and enhanced respiratory disturbances with increases doses of PS. We found no effects of PS on human hERG channels or signs of heart damage in mice. The hypotension in rats and bradycardia in zebrafish were partially attenuated by the inhibitor of endothelial NO synthase. The disturbances in cardiovascular and respiratory parameters were reduced or delayed when PS was administered together with UFH. The cardiorespiratory toxicity of PS seems to be charge–dependent and involves enhanced release of NO. PS administered at appropriate doses and ratios with UFH should not cause permanent damage of heart tissue, although careful monitoring of cardiorespiratory parameters is necessary.
- Open Access
- 15 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205786
Individual variability of vascularization of the anterior papillary muscle within the right ventricle of human heart
To date there is scarce published evidence reporting the dual blood supply reaching anterior papillary muscle (APM), which descends from both major coronary arteries. Such a vascular configuration can prevent the dysfunction of right ventricular entire valvular system in case of the occlusion of proximal part of either right coronary artery (RCA) or left coronary artery (LCA). The aim of our study was to determine the vascular pattern of APM blood supply which originates from two main coronary arteries, in the context of the APM and septomarginal trabecula (SMT) topography. The study was carried out using tissue obtained from 36 human hearts. The material was divided into four morphological types of SMT/APM arrangement. Vascularization and blood supply pattern of papillary muscle was investigated following the analysis of multiple tissue cross sections. The origin of APM arterial supply was traced back to both main coronary arteries. Cross-sectional area of the arteries was estimated at the base of APM and compared within mixed male-female population, aged 18–76. We noted that as much as 78% of entire APM material had a blood supply vasculature originating from both LCA and RCA branches. In contrast, 22% of cases APM was supplied by a single coronary artery, while in each case it proved to be LCA. We have never found APM arterial supply provided exclusively by RCA. In case of double AMP blood supply an average of total cross-section area of the arteries branching from LCA, was noted to be in excess of two and a half times bigger in type III and more than two times bigger in type IV, as compared with the arteries originating from RCA. Our research confirm the possibility of double blood supply which vascularizes APM, but the finding does not necessarily apply in all cases. However, APM seems to be predominantly vascularized by arteries deriving from LCA, regardless of their morphological type.
- 15 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205786
Open AccessIndividual variability of vascularization of the anterior papillary muscle within the right ventricle of human heart
To date there is scarce published evidence reporting the dual blood supply reaching anterior papillary muscle (APM), which descends from both major coronary arteries. Such a vascular configuration can prevent the dysfunction of right ventricular entire valvular system in case of the occlusion of proximal part of either right coronary artery (RCA) or left coronary artery (LCA). The aim of our study was to determine the vascular pattern of APM blood supply which originates from two main coronary arteries, in the context of the APM and septomarginal trabecula (SMT) topography. The study was carried out using tissue obtained from 36 human hearts. The material was divided into four morphological types of SMT/APM arrangement. Vascularization and blood supply pattern of papillary muscle was investigated following the analysis of multiple tissue cross sections. The origin of APM arterial supply was traced back to both main coronary arteries. Cross-sectional area of the arteries was estimated at the base of APM and compared within mixed male-female population, aged 18–76. We noted that as much as 78% of entire APM material had a blood supply vasculature originating from both LCA and RCA branches. In contrast, 22% of cases APM was supplied by a single coronary artery, while in each case it proved to be LCA. We have never found APM arterial supply provided exclusively by RCA. In case of double AMP blood supply an average of total cross-section area of the arteries branching from LCA, was noted to be in excess of two and a half times bigger in type III and more than two times bigger in type IV, as compared with the arteries originating from RCA. Our research confirm the possibility of double blood supply which vascularizes APM, but the finding does not necessarily apply in all cases. However, APM seems to be predominantly vascularized by arteries deriving from LCA, regardless of their morphological type.
- Open Access
- 1 January 2018
- Published by Gdanski Uniwersytet Medyczny in European Journal of Translational and Clinical Medicine
- Vol. 1 (2) , 36-40
A novel approach to visualization of the right ventricular outflow tract
A novel approach to visualization of the right ventricular outflow tract. Introduction: Nowadays, heart is one of the most demanding organs for imaging procedures. This is related to its irregular shape and complex intern...
- 1 January 2018
- Published by Gdanski Uniwersytet Medyczny in European Journal of Translational and Clinical Medicine
- Vol. 1 (2) , 36-40
Open AccessA novel approach to visualization of the right ventricular outflow tract
A novel approach to visualization of the right ventricular outflow tract. Introduction: Nowadays, heart is one of the most demanding organs for imaging procedures. This is related to its irregular shape and complex intern...